Published in Alzheimer Dis Assoc Disord on October 08, 2009
Microinfarct pathology, dementia, and cognitive systems. Stroke (2011) 2.61
Cerebral microinfarcts: the invisible lesions. Lancet Neurol (2012) 2.31
Vascular risk factors and longitudinal changes on brain MRI: the ARIC study. Neurology (2011) 1.92
Microinfarcts, brain atrophy, and cognitive function: the Honolulu Asia Aging Study Autopsy Study. Ann Neurol (2011) 1.65
Cerebral microinfarcts: a systematic review of neuropathological studies. J Cereb Blood Flow Metab (2012) 1.47
Cerebrovascular disease pathology and parkinsonian signs in old age. Stroke (2011) 1.30
Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly. Brain (2015) 1.09
Vascular imaging abnormalities and cognition: mediation by cortical volume in nondemented individuals: atherosclerosis risk in communities-neurocognitive study. Stroke (2015) 1.07
A 2-process model for neuropathology of Alzheimer's disease. Neurobiol Aging (2013) 1.02
Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease. Brain (2011) 1.02
Antemortem MRI findings associated with microinfarcts at autopsy. Neurology (2014) 0.93
Neuropathologic comorbidity and cognitive impairment in the Nun and Honolulu-Asia Aging Studies. Neurology (2016) 0.88
Cross-sectional and longitudinal relationships between cerebrospinal fluid biomarkers and cognitive function in people without cognitive impairment from across the adult life span. JAMA Neurol (2014) 0.86
Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's disease. Acta Neuropathol (2016) 0.85
Alzheimer and vascular neuropathological changes associated with different cognitive States in a non-demented sample. J Alzheimers Dis (2012) 0.85
The Relationship of Cerebral Vessel Pathology to Brain Microinfarcts. Brain Pathol (2016) 0.83
Microinfarcts are common and strongly related to dementia in the oldest-old: The 90+ study. Alzheimers Dement (2016) 0.79
Relations between location and type of intracranial atherosclerosis and parenchymal damage. J Cereb Blood Flow Metab (2015) 0.77
Association of lower hemoglobin level and neuropathology in community-dwelling older persons. J Alzheimers Dis (2012) 0.77
The role of cerebrovascular disease when there is concomitant Alzheimer disease. Biochim Biophys Acta (2015) 0.77
Role of cerebrospinal fluid and plasma biomarkers in the diagnosis of neurodegenerative disorders and mild cognitive impairment. Curr Neurol Neurosci Rep (2011) 0.75
Imaging markers of cerebrovascular pathologies: Pathophysiology, clinical presentation, and risk factors. Alzheimers Dement (Amst) (2016) 0.75
The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord (2006) 8.04
Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol (2007) 4.47
Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci (2002) 3.11
Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol (2000) 2.99
The National Alzheimer's Coordinating Center (NACC) Database: an Alzheimer disease database. Alzheimer Dis Assoc Disord (2004) 2.97
Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons. Ann Neurol (2007) 2.66
Binswanger's disease--revisited. Neurology (1995) 2.56
Neuropathological assessment of the lesions of significance in vascular dementia. J Neurol Neurosurg Psychiatry (1997) 2.05
Senile dementia of the Binswanger type. A vascular form of dementia in the elderly. JAMA (1987) 1.86
Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke (2004) 1.74
Cortical microinfarcts and demyelination affect cognition in cases at high risk for dementia. Neurology (2007) 1.31
Evaluation of selection bias in an incident-based dementia autopsy case series. Alzheimer Dis Assoc Disord (2005) 1.17
Postmortem examination of vascular lesions in cognitive impairment: a survey among neuropathological services. Stroke (2006) 1.05
Neuropathology of progressive cognitive decline in chronically hypertensive rhesus monkeys. Acta Neuropathol (2001) 0.87
Microinfarction as a result of hypertension in a primate model of cerebrovascular disease. Acta Neuropathol (1999) 0.85
Interrater reliability and accuracy in identifying ischemic strokes using computed tomography scans in people with dementia. J Am Geriatr Soc (2005) 0.83
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02
Release from prison--a high risk of death for former inmates. N Engl J Med (2007) 12.46
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement (2009) 10.21
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics (2011) 9.20
The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord (2006) 8.04
The Group Health medical home at year two: cost savings, higher patient satisfaction, and less burnout for providers. Health Aff (Millwood) (2010) 6.60
Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA (2008) 6.04
Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol (2002) 5.69
Patient-centered medical home demonstration: a prospective, quasi-experimental, before and after evaluation. Am J Manag Care (2009) 5.65
Survival after initial diagnosis of Alzheimer disease. Ann Intern Med (2004) 5.52
The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery. Alzheimer Dis Assoc Disord (2009) 5.50
TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol (2008) 5.33
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement (2012) 5.10
The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set. Alzheimer Dis Assoc Disord (2007) 5.01
Glucose levels and risk of dementia. N Engl J Med (2013) 4.95
Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat Biotechnol (2013) 4.85
Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol (2011) 4.76
Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. JAMA (2003) 4.54
Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol (2007) 4.47
The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future. Genet Med (2013) 4.37
Association between acute care and critical illness hospitalization and cognitive function in older adults. JAMA (2010) 4.36
Epidemiologic study of in-hospital cardiopulmonary resuscitation in the elderly. N Engl J Med (2009) 4.23
Rising use of diagnostic medical imaging in a large integrated health system. Health Aff (Millwood) (2008) 4.05
Trends in the prevalence and mortality of cognitive impairment in the United States: is there evidence of a compression of cognitive morbidity? Alzheimers Dement (2008) 4.00
Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: using electronic medical records for genome- and phenome-wide studies. Am J Hum Genet (2011) 3.85
Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol (2012) 3.77
Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol (2014) 3.75
Association of the built environment with physical activity and obesity in older persons. Am J Public Health (2007) 3.60
DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease. Brain (2010) 3.57
Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol (2007) 3.55
Genomic research and wide data sharing: views of prospective participants. Genet Med (2010) 3.45
National estimates of the prevalence of Alzheimer's disease in the United States. Alzheimers Dement (2011) 3.42
Glad you asked: participants' opinions of re-consent for dbGap data submission. J Empir Res Hum Res Ethics (2010) 3.29
The National Alzheimer's Coordinating Center (NACC) Database: an Alzheimer disease database. Alzheimer Dis Assoc Disord (2004) 2.97
Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol (2005) 2.92
Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol (2010) 2.91
Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol (2011) 2.84
International variation in screening mammography interpretations in community-based programs. J Natl Cancer Inst (2003) 2.75
Association of incident dementia with hospitalizations. JAMA (2012) 2.74
Subjective memory deterioration and future dementia in people aged 65 and older. J Am Geriatr Soc (2004) 2.74
Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. JAMA (2013) 2.58
Performance-based physical function and future dementia in older people. Arch Intern Med (2006) 2.57
Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Arch Neurol (2003) 2.56
Long-term survival of adult trauma patients. JAMA (2011) 2.55
CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases. Am J Clin Pathol (2008) 2.34
Age-varying association between statin use and incident Alzheimer's disease. J Am Geriatr Soc (2010) 2.34
Predictors of functional change: a longitudinal study of nondemented people aged 65 and older. J Am Geriatr Soc (2002) 2.30
The epidemiology of narcolepsy. Sleep (2007) 2.28
Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States. Alzheimers Dement (2011) 2.26
Household smoking bans: which households have them and do they work? Prev Med (2003) 2.25
Racial inequities in the timing of breast cancer detection, diagnosis, and initiation of treatment. Med Care (2005) 2.25
Older adults' views of "successful aging"--how do they compare with researchers' definitions? J Am Geriatr Soc (2004) 2.24
Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology (2005) 2.21
GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology (2012) 2.19
The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Arch Neurol (2010) 2.19
Hippocampal sclerosis in advanced age: clinical and pathological features. Brain (2011) 2.16
Regional variation in health care intensity and treatment practices for end-stage renal disease in older adults. JAMA (2010) 2.12
Dental X-rays and the risk of intracranial meningioma: a population-based case-control study. Cancer (2004) 2.11
Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set. Physiol Genomics (2008) 2.11
Neuropathologic substrates of Parkinson disease dementia. Ann Neurol (2012) 2.10
Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis. Am J Kidney Dis (2012) 2.10
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Characteristics of users of online personalized genomic risk assessments: implications for physician-patient interactions. Genet Med (2009) 2.07
Genome- and phenome-wide analyses of cardiac conduction identifies markers of arrhythmia risk. Circulation (2013) 2.06
Genetic variants associated with the white blood cell count in 13,923 subjects in the eMERGE Network. Hum Genet (2011) 2.00
Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. J Alzheimers Dis (2006) 2.00
Implementing the learning health system: from concept to action. Ann Intern Med (2012) 1.99
Current guidelines for using angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease: is the evidence base relevant to older adults? Ann Intern Med (2009) 1.98
Comprehensive search for Alzheimer disease susceptibility loci in the APOE region. Arch Neurol (2012) 1.97
Effectiveness of screening examinations to detect unrecognized exercise-induced bronchoconstriction. J Pediatr (2002) 1.96
Patient experience should be part of meaningful-use criteria. Health Aff (Millwood) (2010) 1.95
Item response theory facilitated cocalibrating cognitive tests and reduced bias in estimated rates of decline. J Clin Epidemiol (2008) 1.93
Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease. J Neurosci (2005) 1.89
Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain. Physiol Genomics (2006) 1.88
Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users. Addiction (2009) 1.88
Protective association between neighborhood walkability and depression in older men. J Am Geriatr Soc (2007) 1.88
Providers' reactions to an automated health maintenance reminder system incorporated into the patient's electronic medical record. J Am Board Fam Pract (2003) 1.87
Extended results of the Alzheimer's disease anti-inflammatory prevention trial. Alzheimers Dement (2011) 1.87
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. Alzheimers Dement (2011) 1.87
Faster plasma vitamin E disappearance in smokers is normalized by vitamin C supplementation. Free Radic Biol Med (2005) 1.85